Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
4.5M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$40.5M
-
Value change
-
+$10M
-
Number of buys
-
23
-
Number of sells
-
-7
-
Price
-
$8.99
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2019
39 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q2 2019.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.5M shares
of 43.4M outstanding shares and own 10.37% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (1.38M shares), BlackRock Inc. (1.15M shares), VANGUARD GROUP INC (612K shares), STATE STREET CORP (288K shares), GEODE CAPITAL MANAGEMENT, LLC (205K shares), NORTHERN TRUST CORP (205K shares), NUVEEN ASSET MANAGEMENT, LLC (63.3K shares), Bank of New York Mellon Corp (56.2K shares), STIFEL FINANCIAL CORP (55.9K shares), and SPHERA FUNDS MANAGEMENT LTD. (50K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.